Could less blood pressure medicine save more lives in heart shock?
NCT ID NCT05168462
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether using less of the drug noradrenaline, by aiming for a lower blood pressure target (55 mmHg instead of 65 mmHg), can improve survival and reduce severe kidney failure in people with cardiogenic shock after a heart attack. About 776 adults will be randomly assigned to one of two blood pressure goals. The main outcomes are death and need for kidney dialysis within 30 days.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOGENIC SHOCK are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Amsterdam UMC, location AMC
RECRUITINGAmsterdam, 1105AZ, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can immune cells predict how well the heart heals after an attack?
- Could a hot bath after exercise help heal the heart?
- Can a Plant-Based diet calm the immune system after a heart attack?
- Can a temporary heart pump save more lives in cardiogenic shock?
- Could a personal trainer cut heart attack deaths?
- Could starting dialysis sooner save more hearts?